Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial using the Multiphase Optimization Strategy (MOST) to optimize a cost-effective, scalable smoking cessation package for people living wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York University | Conditions: Human Immunodeficiency Virus (HIV), Smoking Cessation | Phase 4 | Status: RECRUITING